View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Oncology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 17, 2022
1 min read
Save

Zolbetuximab regimen extends PFS in metastatic gastric, gastroesophageal junction cancers

Zolbetuximab regimen extends PFS in metastatic gastric, gastroesophageal junction cancers

The addition of zolbetuximab to chemotherapy improved PFS among certain patients with gastric or gastroesophageal junction cancers, according to the agent’s manufacturer.

SPONSORED CONTENT
November 16, 2022
2 min read
Save

Follow-up surveillance within 5 years may detect post-colonoscopy CRC

Follow-up surveillance within 5 years may detect post-colonoscopy CRC

CHARLOTTE, N.C. — Recommended surveillance interval was the most important modifiable risk factor for post-colonoscopy colorectal cancer at 3 years, according to research presented at the ACG Annual Scientific Meeting.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
November 14, 2022
1 min read
Save

Onivyde regimen extends OS in metastatic pancreatic ductal adenocarcinoma

Onivyde regimen extends OS in metastatic pancreatic ductal adenocarcinoma

An irinotecan liposome injection regimen improved OS compared with standard chemotherapy among untreated patients with metastatic pancreatic ductal adenocarcinoma, according to the agent’s manufacturer.

SPONSORED CONTENT
November 09, 2022
2 min read
Save

Improved culturally competent care may boost early detection in ‘late-stage HCC hotspots’

Improved culturally competent care may boost early detection in ‘late-stage HCC hotspots’

WASHINGTON — Increased culturally competent care and improved access to medical transport may improve early detection of hepatocellular carcinoma in patients who live in late-stage hotspots, according to researchers at The Liver Meeting.

SPONSORED CONTENT
November 08, 2022
2 min read
Save

‘Significant’ racial, ethnic disparities exist in curative treatment for early-stage HCC

‘Significant’ racial, ethnic disparities exist in curative treatment for early-stage HCC

WASHINGTON — Fewer Black and Hispanic patients received curative treatment for early-stage hepatocellular carcinoma compared with white patients, according to research presented at The Liver Meeting.

SPONSORED CONTENT
November 06, 2022
2 min read
Save

MMaT-3 policy decreases survival, increases recurrence after transplant in HCC patients

MMaT-3 policy decreases survival, increases recurrence after transplant in HCC patients

WASHINGTON — The MELD score at transplant minus three points policy led to poor survival and recurrence outcomes after liver transplantation among patients with hepatocellular carcinoma, according to research at The Liver Meeting.

SPONSORED CONTENT
November 02, 2022
1 min read
Save

FDA grants orphan drug designation to OTX-2002 for hepatocellular carcinoma

FDA grants orphan drug designation to OTX-2002 for hepatocellular carcinoma

The FDA granted orphan drug designation to OTX-2002 for the treatment of hepatocellular carcinoma, according to the agent’s manufacturer.

SPONSORED CONTENT
November 01, 2022
1 min read
Save

Endoscopic ultrasound-guided radiofrequency ablation extends survival in PDAC

Endoscopic ultrasound-guided radiofrequency ablation extends survival in PDAC

CHARLOTTE, N.C. — Endoscopic ultrasound-guided radiofrequency ablation, alone or combined with chemotherapy, improved survival and progression-free survival among a small subset of patients with primary pancreatic ductal adenocarcinoma.

SPONSORED CONTENT
October 31, 2022
1 min read
Save

Achalasia associated with five-fold higher risk for esophageal cancer

Achalasia associated with five-fold higher risk for esophageal cancer

CHARLOTTE, N.C. — Achalasia was associated with an increased risk for esophageal cancer among a cohort of veterans, suggesting the need for increased endoscopic surveillance, according to a presenter at the ACG Annual Scientific Meeting.

SPONSORED CONTENT
October 28, 2022
2 min read
Save

High inflammatory markers tied to poor prognosis, survival in patients with gastric cancer

High inflammatory markers tied to poor prognosis, survival in patients with gastric cancer

CHARLOTTE, N.C. — Elevated baseline neutrophil-to-lymphocyte ratio was associated with distant metastases and poor survival in patients with gastric cancer, according to a presenter at the ACG Annual Scientific Meeting.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails